Device Trial Radar · NCT02710435
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
400
Planned (sponsor's estimate)
Start
Mar 2016
Primary completion
Nov 2023
Study completion Dec 2028
Sponsor
- Lead sponsor
- Shockwave Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 16, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to collect long term data of the Reducer System in subjects with refractory angina pectoris.
Conditions
- Angina Pectoris
- Angina Pectoris, Stable
- Chronic Stable Angina
Interventions
Reducer SystemDevice
An aid in the management of chronic refractory angina pectoris
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction in Canadian Cardiovascular Society (CCS) GradeTime frame: 6 Months
2 more outcomes with a free account
Locations
25 sites in 9 countries. Site status is shown where the registry gives one.
University of Graz
Graz, Austria
24 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.